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A B S T R A C T   
We studied associations between tobacco smoke, home environment and respiratory health in a 10 year follow 
up of a cohort of 11,506 adults in Northern Europe. Multilevel logistic regression models were applied to esti-
mate onset and remission of symptoms. Current smokers at baseline developed more respiratory symptoms (OR 
= 1.39–4.43) and rhinitis symptoms (OR = 1.35). Starting smoking during follow up increased the risk of new 
respiratory symptoms (OR = 1.54–1.97) and quitting smoking decreased the risk (OR = 0.34–0.60). ETS at 
baseline increased the risk of wheeze (OR = 1.26). Combined ETS at baseline or follow up increased the risk of 
wheeze (OR = 1.27) and nocturnal cough (OR = 1.22). Wood painting at baseline reduced remission of asthma 
(OR 95%CI: 0.61, 0.38–0.99). Floor painting at home increased productive cough (OR 95%CI: 1.64, 1.15–2.34) 
and decreased remission of wheeze (OR 95%CI: 0.63, 0.40–0.996). Indoor painting (OR 95%CI: 1.43, 1.16–1.75) 
and floor painting (OR 95%CI: 1.77, 1.11–2.82) increased remission of allergic rhinitis. Living in the oldest 
buildings (constructed before 1960) was associated with higher onset of nocturnal cough and doctor diagnosed 
asthma. Living in the newest buildings (constructed 1986–2001) was associated with higher onset of nocturnal 
breathlessness (OR = 1.39) and rhinitis (OR = 1.34). In conclusion, smoking, ETS and painting indoor can be risk 
factors for respiratory symptoms. Wood painting and floor painting can reduce remission of respiratory symp-
toms. Smoking can increase rhinitis. Living in older buildings can be a risk factor for nocturnal cough and doctor 
diagnosed asthma. Living in new buildings can increase nocturnal dyspnoea and rhinitis.   
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1. Introduction 
The prevalence of asthma in different parts of the world can range 
from 1 to 18% (GINA Report, 2017). Adult asthma is usually more 
common in developed western countries (6.0%–12.0%) (Lundback 
et al., 2016). Rhinitis is a common disease in developed countries. In 
USA and Europe, 10%–20% of the population have allergic rhinitis 
(Ozdoganoglu and Songu, 2012). However, few studies are available on 
incidence of asthma or allergic rhinitis among adults (Wang et al., 
2019a). Home environment exposure can influence respiratory health in 
children (WHO, 2009; Quansah et al., 2012; Mendell, 2007; Mendell 
et al., 2011). One review concluded that chemical emission-related 
materials or activities in dwellings can impair childhood respiratory 
health (Mendell, 2007). However, few have studied associations be-
tween indoor environment in homes and respiratory health in adults 
(Mitchell et al., 2007; Jie et al., 2011). 
Prospective studies have demonstrated that smoking is a risk factor 
for onset of asthma (King et al., 2004; Polosa et al., 2008), but we found 
no prospective studies on smoking and onset of rhinitis. Environmental 
tobacco smoke (ETS) at home is still an important issue. A multicentre 
study from Europe found that ETS was more common in the home (13%– 
40%) than in the workplace (3%–32%) (Heck et al., 2010). ETS exposure 
at home was less common in Northern Europe as compared to central or 
Southern Europe (Heck et al., 2010; Olivieri et al., 2019). A recent Eu-
ropean multicentre study from 2010 to 2014 reported that 9% were 
exposed to ETS at home (Olivieri et al., 2019). This study reported that 
global smoking bans failed to reduce ETS exposure in homes. A number 
of prospective studies have demonstrated that environmental tobacco 
smoke (ETS) is associated with asthma onset in adults (Flexeder et al., 
2019; Coogan et al., 2015; Lajunen et al., 2013; Thorn et al., 2001; 
Jaakkola et al., 2003) and that ETS can increase onset of allergic rhinitis 
in adults (Hur et al., 2014). However, there is a need to study respiratory 
effects of ETS in Northern Europe where the ETS exposure is relatively 
low. 
Few studies have investigated effects of chemical emissions at home 
on adult respiratory symptoms, asthma or rhinitis. Two cross-sectional 
studies from China found that home renovation increased the risk of 
allergic rhinitis (Dong et al., 2013; Li et al., 2014). One incident 
case-control study from Finland found that plastic wall materials in the 
workplace building and floor-levelling plaster at home was related to 
adult onset asthma (Jaakkola et al., 2006). One study from Sweden re-
ported that formaldehyde and VOCs at home increased the risk of 
nocturnal breathlessness among adults (Norback et al., 1995). Indoor 
painting is often a part of the renovation and can cause chemical 
emissions to the home environment. However, little knowledge is 
available on domestic indoor painting and adult respiratory health. One 
recent review (Canova et al., 2013) on domestic painting as a risk factor 
for asthma found only one study on adult asthma. This study reported 
that domestic exposure to newly painted surfaces, especially painted 
wood details and kitchen painting increased adult asthma (Wieslander 
et al., 1997a). We found no previous cohort studies on respiratory effects 
of indoor painting. 
Building age is an important determinant of the indoor environment, 
since different construction techniques and building materials have been 
used in different construction periods. One example is that the energy 
crisis in 1970’ initiated measures to reduce energy consumption in 
Swedish buildings (Engvall et al., 2000). Buildings constructed after this 
period in Sweden were more air-tight buildings and had lower ventila-
tion flow. 
Few studies are available on the role of construction year for respi-
ratory illnesses in adults. One Swedish study found that living in 
buildings constructed after 1975 was associated with airway infections 
(Fu et al., 2015). Another study from Sweden demonstrated that living 
in buildings constructed 1961–1975 increased asthma exacerbation and 
living in buildings constructed 1976–1985 was associated with rhinitis 
(as compared to buildings constructed before 1960) (Wang et al., 2014a, 
2017abib_Wang_et_al_2017abib_Wang_et_al_2014a). One study from 
China reported that adult asthma and allergic rhinitis were more com-
mon in older than in newer buildings (Wang et al., 2019b). We found no 
prospective studies on building age as a risk factor for onset of respira-
tory symptoms, asthma or rhinitis. 
Few prospective studies exist on associations between the home 
environment and respiratory health in Northern Europe. The main aim 
of our study is to investigate associations between smoking, environ-
mental tobacco smoke, indoor painting and building construction year 
and onset and remission of adult respiratory symptoms, asthma and 
rhinitis. 
2. Materials and methods 
2.1. Ethics statement 
This study was approved by the appropriate ethic board in each 
centre. All participants gave informed consent prior to participation. 
2.2. Study design and target population 
The study is based on a 10 year follow up of Respiratory Health in 
Northern Europe (RHINE). The RHINE II study is a follow up study of 
subjects from seven Nordic study centres from the European Community 
Respiratory Health Survey stage I (ECRHS I). The seven centres in 
northern Europe included Reykjavik in Iceland, Bergen in Norway, 
Umeå, Uppsala and Gothenburg in Sweden, Aarhus in Denmark and 
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Tartu in Estonia. The ECRHS I study, conducted in 1989–1992, included 
randomly selected subjects (aged 20–44 years) from the population 
register in each centre (3000–4000 subjects per centre). A postal ques-
tionnaire was then sent to these subjects. 
A total of 21,681 subjects from these seven centres participated in 
ECRHS I (response rate 86%) (Johannessen et al., 2014). In 1999–2000, 
they received a follow up postal questionnaire (RHINE II), with ques-
tions on respiratory health and the home environment. In 2010–2012, 
the RHINE II participants were invited for a second follow up (RHINE 
III), with identical questions on respiratory health as in RHINE II. Totally 
11,506 subjects participated in RHINE II and RHINE III (response rate 
71%). A flow chart of the study design is shown in Fig. 1. Participation 
was defined as reporting at least one of five questions on respiratory 
symptoms (wheeze, nocturnal chest tightness, nocturnal attacks of 
breathlessness, nocturnal cough or asthma attack, see detailed descrip-
tion below). In this article, RHINE II was defined as the baseline study 
and the RHINE III as the follow up study. 
2.3. Respiratory health 
Questions on respiratory symptoms were the same at baseline and at 
follow up. There were five questions on respiratory symptoms in the last 
12 months, including wheeze, nocturnal chest tightness, nocturnal at-
tacks of breathlessness, nocturnal cough and asthma attack. There was 
one question on productive cough, asking “Do you usually bring up 
phlegm or do you have phlegm in your lungs which you have difficulty 
bringing up ?”. One additional question asked about current asthma 
medication (including inhalers, aerosols or tablets). Moreover, there was 
one question on doctor diagnosed asthma and two questions on rhinitis 
(allergic rhinitis and rhinitis symptoms). Current asthma was defined as 
having either asthma attacks or asthma medication, or both (Plaschke 
et al., 2000). The questions have been described in detail in a previous 
publication (Wang et al., 2019a). 
Onset of doctor diagnosed asthma, allergic rhinitis and rhinitis 
symptoms was defined as not reporting the particular respiratory illness 
at baseline but reporting it at follow up. 
Onset of a particular respiratory symptom (wheeze, nocturnal chest 
tightness, nocturnal breathlessness, nocturnal cough, productive cough 
or current asthma) was defined as not reporting the particular symptom 
at baseline but reporting it at follow up (Gunnbjornsdottir et al., 2006). 
Participants with doctor diagnosed asthma at baseline were excluded 
when calculating onset of these respiratory symptoms. 
Remission of a particular respiratory symptom was defined as 
reporting the particular symptom at baseline but not at follow up. Par-
ticipants with doctor diagnosed asthma at baseline were not excluded 
when calculating remission of respiratory symptoms. 
Remission of allergic rhinitis was defined as reporting allergic 
rhinitis at baseline but not at follow up. 
2.4. Home environment 
Environment tobacco smoke (ETS) was asked about at baseline and 
at follow up, using the same question: “Does tobacco smoking take place 
in your present home?”. There were four alternatives: yes, daily; yes, 
often, 1–4 times per week; yes sometimes, 1–3 times per month; no, 
never. One new variable (“ETS at baseline”) was created, coded as 0 if 
the answer was “no” at baseline, coded as 1 if the answer was “yes, 
sometimes, 1–3 times per month”, and coded as 2 if the answer was yes 
daily” or “yes, often, 1–4 times per week”. Another variable (“ETS at 
follow up”) was defined in the same way. A combined ETS variable was 
then created, coded as 0 if both ETS at baseline and ETS at follow up 
equal 0, coded as 2 if any of the two variables equals 2, and coded as 1 if 
any of the two variables equals 1 but not 2. 
The baseline questionnaire included questions on indoor painting, 
type of dwelling and construction year of the building. Two questions 
asked on indoor painting: “Have the inside of your dwelling been 
painted in the past 12 months?” and “What was painted?”, giving six 
alternatives for location of the indoor painting: ceilings, walls, 
carpentry/wooden details, floors, metal pipes/radiators and other. 
There was one question on type of dwelling, with four alternatives: 
detached, semi-detached, apartment and other. Moreover, there was one 
question on construction year of the building. 
2.5. Other covariate variables 
Data on gender and age were collected from the baseline data. Height 
and weight were obtained from baseline and follow up data. Body mass 
index (BMI) at baseline and follow up were calculated as the ratio of 
weight in kilograms to height in meters squared (kg/m2). Change of BMI 
from baseline to follow up was calculated. Information on education 
level was only available at follow up. Education level was categorized as 
primary school, high school or university education. Information on 
smoking habit (never/ex-smokers/current smokers) was available at 
baseline and at follow up. A variable on change of smoking from base-
line to follow up (no change/start smoking/quit smoking) was created. 
Smoking at baseline or follow up was defined as: yes, current smokers at 
baseline or follow up; no, never smokers or ex-smokers at baseline and 
follow up. Questions on building dampness at baseline asked about four 
dampness indicators in the past 12 months: water damage (yes/no), 
floor dampness (yes/no), visible mould (yes/no) and mould odour (yes/ 
no). Questions on building dampness at follow up included only three 
dampness indicators (in the past 12 months): water damage (yes/no), 
floor dampness (yes/no) and visible mould (yes/no). A variable called 
any dampness at baseline (yes/no) was created based on at least one yes 
answer to the four dampness indicators at baseline. Change of dampness 
at home from baseline to follow up was calculated, including data on 
three dampness indicators that available both at baseline and follow up 
(water damage, floor dampness and visible mould). A detailed descrip-
tion of the dampness questions is available in a previous publication 
(Wang et al., 2019a). 
2.6. Statistical analysis 
The statistical analysis was performed by Stata 15.1 (Stata Corpo-
ration, College Station, Texas, USA). Initially, two level (centre, indi-
vidual) logistic regression models were used to estimate associations 
between smoking habits and onset of respiratory symptoms, doctor 
diagnosed asthma, allergic rhinitis and rhinitis symptoms. The models 
included gender, age, smoking at baseline, change of smoking habit 
from baseline to follow up, BMI at baseline, change of BMI from baseline 
to follow up, education level at follow up, any dampness at baseline and 
change of dampness from baseline to follow up (nine covariates). Fig. 1. Flow chart of the study design.  
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Subjects with doctor diagnosed asthma at baseline were excluded when 
analysing onset of respiratory symptoms. Associations between ETS at 
baseline, the combined ETS variable, painting, construction year and 
type of dwelling and onset of respiratory symptoms, doctor diagnosed 
asthma, allergic rhinitis and rhinitis symptoms were analysed using two 
level logistic regression models, adjusting for the nine covariates. 
Stratified analyses (current smokers at baseline or follow up vs. never 
smokers or ex-smokers at baseline and follow up) were performed, 
adjusting for the nine covariates. Additional two level logistic regression 
models were conducted to study the associations between ETS at base-
line and onset of symptoms, including only those were current smokers 
at baseline and adjusting for how much participants smoked at baseline. 
Interaction between ETS at baseline and smoking at baseline or 
follow up (yes/no) in association with onset of respiratory symptoms, 
doctor diagnosed asthma, allergic rhinitis and rhinitis symptoms were 
analysed (p < 0.1 was considered to be significant for interaction 
analyses). 
Moreover, two level logistic regression models were applied to esti-
mate associations between home environment factors and remission of 
respiratory symptoms and allergic rhinitis, adjusting for the nine cova-
riates. In order to detect heterogeneity between centres, adjusted ORs 
were calculated separately for each centre. An average effect estimate 
was derived, and heterogeneity between centres was examined (p < 0.1) 
using standard methods for random effects meta-analysis. Associations 
were expressed as odds ratios (OR) with a 95% confidence interval (CI), 
and 5% significance level. 
3. Results 
A total of 11,506 subjects participated in RHINE II and RHINE III, 
54.3% were females. The mean age at baseline was 40 (SD = 7.3) years. 
The mean follow up time was 11.3 ± 1.1 years. Current smoking (26.3%) 
and ex-smoking (26.4%) were common at baseline. During follow up, 
2.4% started smoking and 12.1% quitted smoking. Non-participants in 
RHINE II and RHINE III had slightly higher prevalence of respiratory 
symptoms as compared to participants in RHINE II and RHINE III (Wang 
et al., 2019a). 
Table 1 shows the prevalence of ETS inside the home, stratified for 
smoking habits. Totally 37.3% of the homes had ETS at baseline, 13.0% 
had ETS at follow up, and 39.2% had ETS at baseline or follow up. 
Smokers were more often exposed to ETS at baseline and at follow up (p 
< 0.001). The prevalence of smokers not exposed to ETS increased from 
29.0% at baseline to 67.9% at follow up, suggesting a strong trend of 
avoiding smoking inside of the home. 
Data on the home environment is shown in Table 2. Indoor painting 
in the last 12 months was common (36.9%), 14.6% had painting on 
wood and 4.5% had painting on floor. Data on painting on ceilings 
(21.8%), walls (29.6%), metal pipes/radiators (8.2%) and other places 
(1.9%) is given in text only. Most of the participants lived in a detached/ 
semidetached house (59.8%) or apartment (38.5%) at baseline. A third 
(36.3%) lived in buildings constructed before 1960. Exposure to ETS at 
baseline was most common in Aarhus, any indoor painting was most 
common in Reykjavik, and wood painting and floor painting were most 
common in Tartu. ETS, indoor painting, wood painting and floor 
painting were more common in homes with dampness at baseline (p <
0.001). Newer buildings had less dampness at baseline. 
Onset and remission rates of respiratory illnesses are shown in 
Table 3. A total of 9.9% had new onset of wheeze, 9.3% had new onset of 
productive cough, 4.3% had new onset of doctor diagnosed asthma, and 
9.5% had new onset of allergic rhinitis. Onset of rhinitis symptoms was 
most common (25.9%). The remission rate was high, 47.5%–66.9% of 
the participants with a particular respiratory symptom at baseline were 
free from having that symptom at follow up. 
In the crude data analyses (Table 3), ETS at baseline was related to 
onset of wheeze, nocturnal chest tightness, nocturnal attacks of 
breathlessness, nocturnal cough, productive cough, current asthma, 
allergic rhinitis and rhinitis symptoms. Any indoor painting and wood 
painting were related to onset of allergic rhinitis. Floor painting was 
related to onset of nocturnal chest tightness, nocturnal attacks of 
breathlessness and productive cough. Moreover, weekly exposure to ETS 
at baseline was related to less remission of wheeze. Floor painting was 
related to less remission of nocturnal cough. Weekly exposure to ETS at 
baseline, any indoor painting and floor painting were all related to 
remission of allergic rhinitis. Onset and remission rates of respiratory 
symptoms, asthma, allergic rhinitis and rhinitis symptoms stratifying for 
construction year are shown in Supplement Table 1. Onset of nocturnal 
cough was most common in buildings constructed before 1960 (p =
0.043). Onset of rhinitis symptoms was most common among those 
living in buildings constructed during 1986–2001 (p = 0.001). No as-
sociations were found between type of dwelling (apartment vs. 
detached/semi-detached house) and onset or remission of respiratory 
symptoms, asthma or rhinitis (data not shown). 
Health associations for smoking habits and ETS are shown in Table 4. 
Being an ex-smoker at baseline was related to onset of wheeze and 
rhinitis symptoms. Being a current smoker at baseline was associated 
with onset of all respiratory health variables except doctor diagnosed 
asthma and allergic rhinitis. Starting smoking during follow up 
increased onset of wheeze, nocturnal cough and productive cough. 
Quitting smoking during follow up decreased onset of wheeze and 
productive cough. Weekly exposure to ETS at baseline was related to 
onset of wheeze. Weekly exposure to ETS at baseline or follow up was 
related to onset of wheeze and nocturnal cough. 
Table 5 shows associations between respiratory health and painting 
and construction year. There was a trend of association between wood 
painting and onset of allergic rhinitis (p = 0.05). Floor painting was 
associated with onset of productive cough. Participants living in build-
ings constructed from 1961 to 1975 had less onset of nocturnal cough, 
and those living in buildings constructed from 1976 to 1985 had less 
onset nocturnal cough and doctor diagnosed asthma. Living in buildings 
constructed from 1986 to 2001 increased onset of nocturnal breath-
lessness and rhinitis symptoms but reduced onset of nocturnal cough. 
Increased building age was associated with higher onset of nocturnal 
cough (p = 0.016). There was no difference in health associations be-
tween apartment and detached/semi-detached house (data not shown). 
The associations between construction year and onset of respiratory 
symptoms, asthma and rhinitis did not change with additional adjust-
ment of type of dwelling in the models. 
Associations between ETS at baseline and respiratory health are 
shown in Table 6. Among current smokers at baseline or at follow up, 
weekly exposure to ETS was associated with onset of wheeze, nocturnal 
chest tightness and productive cough. The associations between ETS and 
wheeze and nocturnal chest tightness were stronger among smokers 
than non-smokers (p value for interaction were 0.083 and 0.021, 
Table 1 
The prevalence of ETS (%) inside the home (n = 11,506).    
Total Smokera      
Yes No pb 
ETS at baseline Never 62.3 29.0 75.4  
Sometimes 15.7 16.0 15.7  
Weekly 22.0 55.0 8.9 <0.001 
ETS at follow up Never 87.0 67.9 94.6  
Sometimes 4.1 8.0 2.6  
Weekly 8.9 24.2 2.8 <0.001 
Combined ETS c 0 60.8 26.4 74.3  
1 15.7 15.6 15.9  
2 23.5 58.0 9.8 <0.001  
a Smoker was defined as: yes, current smokers at baseline or follow up; no, ex/ 
never smokers at baseline and follow up. 
b Chi-square test. 
c ETS at baseline or follow up: coded as 0, never; 1, sometimes but not weekly; 
2, weekly. 
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respectively). Extra analyses including only current smokers at baseline, 
adjusting for how much they smoked, showed that weekly exposure to 
ETS at baseline was related to onset of wheeze (OR 95%CI: 1.70, 
1.29–2.42, p = 0.003). 
Associations between ETS at baseline and remission of respiratory 
symptoms, asthma and rhinitis are shown in Supplement Table 2. There 
were no associations. Extra analyses for ETS at baseline or follow up and 
remission of symptoms showed that weekly exposure to ETS (at baseline 
or follow up) decreased remission of nocturnal breathlessness (OR 95% 
CI: 0.56, 0.31–0.998, p = 0.049). Wood painting was associated with 
less remission of current asthma. Floor painting was associated with less 
remission of wheeze. Any indoor painting and floor painting increased 
remission of allergic rhinitis. No associations were found between type 
of dwelling and remission of symptoms. Moreover, we found no 
associations between construction year and remission of respiratory 
symptoms, asthma or rhinitis. 
Meta-analysis was used to detect heterogeneity between centres 
(Figs. 2-4). The estimates from the meta-analyses were almost identical 
to those derived when analysing the pooled data by multilevel logistic 
regression. There was no centre heterogeneity between ETS at baseline 
(never vs. sometimes or weekly) and onset of wheeze (Fig. 2). Moreover, 
there was no centre heterogeneity between floor painting and onset of 
productive cough (Fig. 3), or between wood painting and onset of 
allergic rhinitis (Fig. 4). 
4. Discussions 
Few studies have investigated respiratory effects in adults of other 
Table 2 



















p            
Yes No  
ETS at 
baseline 
Never 62.3 30.7 49.6 57.6 76.2 83.6 85.4 53.3  58.5 63.4  
Sometimes 15.7 35.0 17.7 17.2 9.1 6.6 6.5 14.8  16.8 15.3  
Weekly 22.0 34.3 32.7 25.2 14.7 9.8 8.1 31.9 <0.001 24.7 21.3 <0.001 
Any indoor 
painting 
Yes 36.9 42.3 48.5 39.8 31.4 27.0 29.6 40.6  43.3 35.1  
No 63.1 57.7 51.5 60.2 68.6 73.0 70.4 59.4 <0.001 56.7 64.9 <0.001 
Wood 
painting 
Yes 14.6c 17.7 7.4 12.6 Missingd 13.2 16.5 22.2  18.0 13.7  
No 85.4 82.3 92.6 87.3 Missingd 86.8 83.5 77.8 <0.001 82.0 86.3 <0.001 
Floor painting Yes 4.5c 3.5 4.4 2.8 Missingd 2.7 2.7 14.5  6.6 3.9  





36.3 45.3 27.3 31.7 39.4 38.5 39.5 28.7  41.0 35.1   
1961–1975 23.3 22.8 22.8 20.6 29.9 21.7 23.5 22.7  25.0 22.7   
1976–1985 20.5 15.7 21.6 20.5 14.4 27.1 21.1 24.0  19.5 20.9   
1986–2001 19.9 16.3 28.4 27.1 16.4 12.7 16.0 24.6 <0.001 14.6 21.3 <0.001  
a Chi-square test. 
b Any dampness at baseline was defined as occurrence of any of the four dampness indicators in the past 12 months: water damage, floor dampness, visible mould or 
mould odour. 
c The total prevalence was based on data from Aarhus, Reykjavik, Bergen, Umeå, Uppsala and Tartu. 
d Data for type of painting was missing in Gothenburg. 
Table 3 






Any indoor painting 
(%) 
Wood painting (%) Floor painting (%)    
Never Sometimes Weekly pa Yes No pa Yes No pa Yes No pa 
Onset Wheeze 9.9 7.9 9.9 16.4 <0.001 10.5 9.5 0.134 10.3 9.9 0.664 12.0 9.8 0.195  
Nocturnal chest 
tightness 
7.2 6.2 7.5 9.9 <0.001 7.3 7.2 0.761 8.2 7.1 0.204 9.9 7.2 0.049  
Nocturnal attacks of 
breathlessness 
3.7 3.4 3.4 4.6 0.027 3.5 3.8 0.387 4.0 3.8 0.705 6.1 3.7 0.017  
Nocturnal cough 17.0 16.0 16.4 20.8 <0.001 17.1 17.1 0.982 19.0 16.7 0.077 20.8 16.8 0.098  
Productive cough 9.3 8.1 9.3 13.3 <0.001 9.1 9.5 0.493 9.0 9.4 0.715 13.7 9.1 0.005  
Current asthma b 4.1 3.9 3.6 5.1 0.030 4.1 4.1 0.973 3.4 4.3 0.126 3.6 4.2 0.543  
Ever doctor 
diagnosed asthma 
4.3 4.2 4.0 4.9 0.299 4.5 4.2 0.458 4.3 4.7 0.560 5.3 4.6 0.519  
Allergic rhinitis 9.5 8.8 10.4 10.7 0.026 10.5 8.9 0.016 11.7 9.5 0.022 13.0 9.7 0.050  
Ever rhinitis 
symptoms 
25.9 24.4 28.2 28.5 0.004 25.9 25.7 0.880 27.3 25.9 0.444 29.5 26.2 0.262 
Remission Wheeze 47.5 48.5 52.9 43.9 0.022 47.4 47.4 0.995 45.8 47.9 0.517 38.9 48.1 0.062  
Nocturnal chest 
tightness 
66.9 67.9 63.1 67.5 0.482 65.5 68.2 0.338 62.7 66.9 0.298 64.6 66.3 0.782  
Nocturnal attacks of 
breathlessness 
65.8 69.5 65.3 60.6 0.158 65.5 66.9 0.745 62.0 66.6 0.438 60.7 66.1 0.559  
Nocturnal cough 48.2 47.5 50.5 48.2 0.486 49.5 47.3 0.221 47.1 48.4 0.612 37.3 48.8 0.005  
Productive cough 54.8 55.7 58.9 51.0 0.072 56.2 54.2 0.424 59.0 55.2 0.259 52.1 56.0 0.524  
Current asthma b 38.9 36.9 40.7 43.2 0.368 40.4 37.6 0.472 31.5 39.7 0.111 36.4 38.4 0.817  
Allergic rhinitis 24.7 22.0 26.3 32.3 <0.001 28.5 22.5 0.001 27.5 24.3 0.204 34.9 24.3 0.013  
a Chi-square test. 
b Current asthma was defined as either asthma attack, asthma medication or both. 
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home environment factors than dampness and mould. Our study is one 
of the first prospective studies simultaneously investigating associations 
between smoking, environmental tobacco smoke, indoor painting, 
building construction year and onset and remission of adult respiratory 
symptoms, asthma and rhinitis. We found that risk factors for asthma 
and rhinitis may differ. Smoking was related to onset of respiratory 
symptoms and rhinitis symptoms. Starting smoking during follow up 
increased onset of respiratory symptoms and quitting smoking at follow 
up decreased the risk. ETS was associated with increased onset of 
wheeze. Wood painting decreased remission of current asthma. Floor 
painting increased onset of productive cough and decreased remission of 
wheeze. Indoor painting, especially floor painting increased remission of 
allergic rhinitis. Living in older buildings was a risk factor for onset of 
nocturnal cough and doctor diagnosed asthma. Living in new buildings 
was a risk factor for nocturnal dyspnoea and rhinitis. 
Table 4 
Adjusted odds ratios with 95% confidence intervals (CI) for onset of respiratory symptoms, current asthma, doctor diagnosed asthma and rhinitis in relation to smoking 
at baseline, change of smoking habit from baseline to follow up, ETS at baseline and combined ETS.   
Smoking at 
baselinea,c  
Change of smoking from 




ETSb,f   
Ex-smoker Current smoker Start smoking Quit smoking Sometimes Weekly 1 2 
Wheeze 1.09(0.88,1.36) 4.43 
(3.61,5.45) 
*** 







































Nocturnal cough 0.94(0.79,1.11) 1.69 
(1.39,2.05) 
*** 










Productive cough 0.95(0.77,1.18) 2.52 
(2.03,3.12) 
*** 































































***p < 0.001, **p < 0.01, *p < 0.05. 
a Two level logistic regression models (centre, individual), including age (follow up), gender (baseline), smoking (baseline), change of smoking habit from baseline 
to follow up, BMI (baseline), change of BMI from baseline to follow up, education (follow up), any dampness (baseline) and change of dampness from baseline to follow 
up. 
b Two level logistic regression models (centre, individual), adjusted for age (follow up), gender (baseline), smoking (baseline), change of smoking habit from 
baseline to follow up, BMI (baseline), change of BMI from baseline to follow up, education (follow up), any dampness (baseline) and change of dampness from baseline 
to follow up. 
c Reference group: never smoker. 
d Reference group: no change. 
e Reference group: never. 
f ETS at baseline or follow up: coded as 0, never; 1, sometimes but not weekly; 2, weekly. Reference group: 0, never. 
Table 5 
Adjusted odds ratios with 95% confidence intervals (CI) for onset of respiratory symptoms, current asthma, doctor diagnosed asthma and rhinitis in relation to indoor 
painting and construction year.   
Any indoor painting Wood painting Floor painting Construction yeara       
1961–1975 1976–1985 1986–2001 
Wheeze 1.13(0.96,1.33) 1.09(0.86,1.37) 0.89(0.58,1.37) 0.86(0.69,1.07) 0.79(0.63,0.99) 0.98(0.78,1.22) 
Nocturnal chest tightness 1.03(0.86,1.22) 1.16(0.91,1.48) 1.26(0.85,1.87) 0.86(0.68,1.09) 0.84(0.65,1.08) 1.01(0.79,1.28) 
Nocturnal breathlessness 0.88(0.69,1.12) 0.92(0.66,1.30) 1.20(0.73,1.97) 1.23(0.90,1.68) 0.81(0.56,1.17) 1.39(1.01,1.92) * 
Nocturnal cough 0.99(0.86,1.14) 1.16(0.95,1.41) 1.01(0.70,1.44) 0.81(0.67,0.97) * 0.78(0.64,0.94) ** 0.74(0.61,0.90) ** 
Productive cough 0.97(0.82,1.14) 0.98(0.77,1.25) 1.64(1.15,2.34) ** 0.98(0.79,1.21) 0.82(0.65,1.03) 0.94(0.75,1.19) 
Current asthma 0.98(0.78,1.23) 0.86(0.61,1.22) 0.74(0.39,1.42) 0.77(0.57,1.04) 0.81(0.59,1.10) 0.90(0.67,1.22) 
Doctor diagnosed asthma 1.03(0.83,1.28) 0.99(0.73,1.35) 1.24(0.75,2.07) 0.74(0.56,0.99) 0.67(0.49,0.91) * 0.83(0.62,1.12) 
Allergic rhinitis 1.11(0.94,1.30) 1.24(1.00,1.55)b 1.32(0.92,1.90) 0.99(0.80,1.22) 0.80(0.63,1.01) 0.95(0.76,1.19) 
Rhinitis symptoms 0.94(0.82,1.08) 1.02(0.84,1.25) 1.01(0.71,1.42) 1.06(0.88,1.26) 0.96(0.80,1.16) 1.34(1.12,1.61) ** 
Two level logistic regression models (centre, individual), adjusted for age (follow up), gender (baseline), smoking (baseline), change of smoking habit from baseline to 
follow up, BMI (baseline), change of BMI from baseline to follow up, education (follow up), any dampness (baseline) and change of dampness from baseline to follow 
up. 
***p < 0.001, **p < 0.01, *p < 0.05. 
a Reference group: constructed before 1960. 
b p = 0.05. 
J. Wang et al.                                                                                                                                                                                                                                    
Environmental Research 192 (2021) 110269
7
4.1. Methodological issues 
Selection bias should not be a major problem in the initial postal 
questionnaire study (ECRHS I) since the participation rate was high 
(Johannessen et al., 2014). Moreover, the response rate from RHINE II to 
RHINE III was reasonable (71%), and it has been previously demon-
strated that exposure-outcome associations were not influenced by loss 
to follow up (Johannessen et al., 2014). Nonparticipants in RHINE II had 
slightly higher prevalence of respiratory symptoms in ECRHS I as 
compared to participants ECRHS I, but the prevalence of allergic rhinitis 
was lower. Nonparticipants in RHINE III had slightly higher prevalence 
of respiratory symptoms and asthma in RHINE II as compared to par-
ticipants in RHINE II, but the prevalence of dampness indicators at 
baseline (RHINE II) did not differ between participants and 
nonparticipants in RHINE III. Most exposure data, including ETS, con-
struction year, indoor painting and type of dwelling were collected at 
baseline to reduce recall bias. Moreover, similar results were obtained in 
the crude and multivariate data analysis. Thus, our results are unlikely 
to be influenced by selection or information bias. 
4.2. Different risk factors for asthma and rhinitis 
Some studies have demonstrated that risk factors for asthma and 
rhinitis can differ. One study from China found that living close to heavy 
trafficked roads, redecoration, visible mould and window pane 
condensation were all risk factors for allergic rhinitis among adults, but 
only water damage was related to asthma (Wang et al., 2014b). More-
over, the Chinese study found different risk factors for childhood asthma 
Table 6 
Adjusted odds ratios with 95% confidence intervals (CI) for onset of respiratory symptoms, current asthma, doctor diagnosed asthma and rhinitis in relation to ETS at 
baseline, stratified for smoking at baseline or follow up, and the interaction between ETS at baseline and smoking.    
Smoking at baseline or follow upa    
Yes p No p p for Interactionb 
Wheeze Sometimes 1.18(0.80,1.74) 0.403 0.98(0.75,1.30) 0.913 0.083  
Weekly 1.60(1.20,2.13) 0.001 1.15(0.83,1.60) 0.406  
Nocturnal chest tightness Sometimes 1.06(0.64,1.76) 0.813 1.10(0.82,1.47) 0.529 0.021  
Weekly 1.74(1.20,2.52) 0.003 0.84(0.58,1.24) 0.387  
Nocturnal breathlessness Sometimes 1.34(0.73,2.46) 0.351 0.83(0.54,1.28) 0.400 0.332  
Weekly 1.47(0.92,2.36) 0.110 0.96(0.58,1.58) 0.869  
Nocturnal cough Sometimes 0.95(0.66,1.36) 0.763 1.06(0.83,1.35) 0.641 0.436  
Weekly 1.12(0.85,1.48) 0.430 1.29(0.98,1.69) 0.069  
Productive cough Sometimes 1.26(0.85,1.87) 0.251 1.04(0.77,1.40) 0.813 0.270  
Weekly 1.37(1.01,1.86) 0.046 1.09(0.77,1.54) 0.630  
Current asthma Sometimes 1.06(0.61,1.85) 0.835 0.74(0.49,1.12) 0.159 0.390  
Weekly 1.04(0.68,1.60) 0.841 0.87(0.54,1.42) 0.585  
Doctor diagnosed asthma Sometimes 0.88(0.48,1.64) 0.693 0.83(0.57,1.20) 0.326 0.277  
Weekly 1.08(0.69,1.69) 0.738 0.73(0.46,1.18) 0.203  
Allergic rhinitis Sometimes 0.91(0.59,1.42) 0.687 1.14(0.87,1.49) 0.345 0.314  
Weekly 0.93(0.66,1.31) 0.671 1.09(0.78,1.53) 0.615  
Rhinitis symptoms Sometimes 1.22(0.86,1.73) 0.265 1.16(0.93,1.44) 0.184 0.342  
Weekly 1.00(0.76,1.31) 0.979 1.02(0.77,1.35) 0.908  
Two level logistic regression models (centre, individual), adjusted for age (follow up), gender (baseline), BMI (baseline), change of BMI from baseline to follow up, 
education (follow up), any dampness (baseline) and change of dampness from baseline to follow up. 
a Smoking at baseline or follow up: yes, current smokers at baseline or follow up; no, ex/never smokers at baseline and follow up. 
b Interaction: Interaction between ETS baseline and smoking at baseline or follow up (yes/no) in association with onset of respiratory symptoms, current asthma, 
doctor diagnosed asthma and rhinitis. Two level logistic regression models (centre, individual), including age (follow up), gender (baseline), BMI (baseline), change of 
BMI from baseline to follow up, education (follow up), any dampness (baseline) and change of dampness from baseline to follow up in the models. 
Fig. 2. Adjusted odds ratios and 95% CIs of wheeze in subjects reporting ETS at 
baseline with a combined odds ratio (diamond indicates 95% CI) from the 
model with centre as the random effect. The models were adjusted for age 
(follow up), gender (baseline), smoking (baseline), change of smoking habit 
from baseline to follow up, BMI (baseline), change of BMI from baseline to 
follow up, education (follow up), any dampness (baseline) and change of 
dampness from baseline to follow up. 
Fig. 3. Adjusted odds ratios and 95% CIs of productive cough in subjects 
reporting floor painting with a combined odds ratio (diamond indicates 95% CI) 
from the model with centre as the random effect. The models were adjusted for 
age (follow up), gender (baseline), smoking (baseline), change of smoking habit 
from baseline to follow up, BMI (baseline), change of BMI from baseline to 
follow up, education (follow up), any dampness (baseline) and change of 
dampness from baseline to follow up. 
J. Wang et al.                                                                                                                                                                                                                                    
Environmental Research 192 (2021) 110269
8
and rhinitis (Norback et al., 2018). One study from Sweden reported that 
ETS, indoor painting and odour were risk factors for adult asthma, while 
only window pane condensation was related to adult allergic rhinitis 
(Wang et al., 2014a). Another study from Sweden found that lower air 
exchange rate increased the risk of adult asthma while higher moisture 
load was a risk factor for rhinitis in adults (Wang et al., 2017b). The 
reason that risk factors can differ for asthma and rhinitis is unclear. 
Different particle size and different degree of water solubility can in-
fluence exposure in upper and lower airways. For instance, big particles 
as well as water soluble compounds are more likely to be deposited in 
the nose, but smaller particles and compounds with lower degree of 
water solubility are more likely to be deposited in the lower airways 
(Shusterman, 2003). 
4.3. Smoking in relation to onset of respiratory symptoms and rhinitis 
symptoms 
Our study found that smoking increased onset of respiratory symp-
toms and rhinitis symptoms. Moreover, we found that starting smoking 
increased onset of respiratory symptoms and quitting smoking 
decreased onset of respiratory symptoms. Our results on smoking are in 
agreement with previous studies. Adult smokers were more likely to 
develop asthma than those who had never smoked, showed in one re-
view including only prospective studies (King et al., 2004). One cohort 
study from Italy including non-asthmatic adults with allergic rhinitis 
found that smoking increased the risk of incident asthma (Polosa et al., 
2008). However, we found no previous prospective studies on smoking 
in relation to onset of rhinitis in adults. 
4.4. ETS in relation to onset of respiratory symptoms 
Despite smoking bans in public places in the Northern countries, 
37.7% of the participants in our study were still exposed to ETS in the 
home at baseline. However, the prevalence of ETS at home was reduced 
to 13% at follow up. The reduction of indoor ETS occurred among non- 
smokers as well as among smokers. ETS at baseline was associated with 
onset of wheeze. This is in agreement with previous studies. One lon-
gitudinal study from Europe reported that ETS was related to onset of 
asthma and asthma symptoms (Flexeder et al., 2019). One longitudinal 
study from US found that ETS increased adult onset of asthma (Coogan 
et al., 2015). One population-based case-referent study from Sweden 
found that ETS was associated with onset of doctor diagnosed asthma 
(Thorn et al., 2001). Moreover, one population-based case-control study 
from Finland showed that ETS exposure at work was related to adult 
onset asthma. The study found a synergistic effect between asthma he-
redity (parental asthma) and exposure to ETS on adult onset asthma 
(Lajunen et al., 2013; Jaakkola et al., 2003). 
We found that the respiratory effects of ETS was stronger among 
smokers than non-smokers. This could be because the smokers had a 
higher exposure to ETS, or because the combination of own smoking and 
ETS exposure had a stronger respiratory effect. More detailed studies on 
ETS exposure are needed in future studies. 
4.5. Indoor painting in association with onset and remission of adult 
respiratory symptoms, asthma and rhinitis 
Our study found that floor painting at baseline was associated with 
increased onset of productive cough and decreased remission of wheeze. 
Moreover, we found that wood painting was associated with less 
remission of current asthma. Wood painting can be a source of formal-
dehyde. Higher indoor formaldehyde concentrations were found in 
Swedish dwellings with wood painting (Wieslander et al., 1997a). There 
are few epidemiological studies on indoor painting and adult respiratory 
symptoms (Canova et al., 2013). One Swedish cross-sectional study 
found that domestic painting of wood details were related to adult 
asthma (Wieslander et al., 1997a). Elevated chemical emissions in new 
buildings from indoor painting can last up to six months 
(SverreBjørnHoløs et al., 2017). Being exposed to paints emissions may 
trigger later development of respiratory illnesses. Three cohort studies 
from Sweden (each with a 10-year follow up time) investigated effects of 
indoor painting on sick building syndrome (SBS) symptoms. The studies 
found that indoor painting increased SBS symptoms (Sahlberg et al., 
2009) and incidence of general symptoms (Sahlberg et al., 2012). 
Moreover, indoor painting at baseline decreased remission of general 
symptoms (Sahlberg et al., 2010). 
Any indoor painting and floor painting were related to increased 
remission of allergic rhinitis. One explanation could be that indoor 
painting and related renovation activities can benefit indoor environ-
ment by removing dirt, allergens and other indoor pollutants. One study 
on allergen levels in Germany day care centres showed that house dust 
mite allergens decreased significantly when rooms were renovated 
(Sander et al., 2016). Another intervention study from US found that 
cockroach and mouse allergen loads were reduced after house renova-
tion (Jacobs et al., 2014). 
One third of the homes in our study had been painted indoors in the 
last 12 months. Newly applied paints can emit volatile organic com-
pounds (VOCs) and the emissions can last for a long time (Sparks et al., 
1999). The indoor concentration of VOCs from indoor paints can differ 
depending on the type of paint used, the nature of the painted surfaces 
and the ventilation flow (Canova et al., 2013). There are two main types 
of indoor paints: water-based paints and solvent-based paints. 
Solvent-based paints produce rapid and high emissions of non-polar 
organic solvents. VOCs concentrations can be 100 times higher from 
solvent-based paints as compared to water-based paints (Wieslander 
et al., 1997b). Water-based paints are commonly used in Sweden 
nowadays (Sahlberg et al., 2009; Wieslander et al., 1994, 1997bbib_-
Wieslander_et_al_1997bbib_Wieslander_et_al_1994), but solvent paints 
can be used for specific applications such as painting on wood or metal 
surfaces. One Swedish study reported that working in a newly redeco-
rated building painted with water-based paints increase nasal inflam-
mation in office workers (Wieslander et al., 1999). Little is known about 
types of paints used in different European countries. It is mentioned in 
one recent review that European manufacturers are demanded by law to 
produce paint with low concentrations of VOC and in many countries 
low-VOC paints are mandatory (Canova et al., 2013). 
Fig. 4. Adjusted odds ratios and 95% CIs of allergic rhinitis in subjects 
reporting wood painting with a combined odds ratio (diamond indicates 95% 
CI) from the model with centre as the random effect. The models were adjusted 
for age (follow up), gender (baseline), smoking (baseline), change of smoking 
habit from baseline to follow up, BMI (baseline), change of BMI from baseline to 
follow up, education (follow up), any dampness (baseline) and change of 
dampness from baseline to follow up. 
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4.6. Building age in association with adult onset of asthma and rhinitis 
Living in older buildings (constructed before 1960) was associated 
with onset of nocturnal cough and doctor diagnosed asthma. Living in 
newer buildings, constructed in 1986–2001, was related to higher onset 
of nocturnal breathlessness. To our knowledge, our study is the first 
incident study investigating building age as a risk factor for adult res-
piratory health. One cross-sectional study from China reported that 
adults living in buildings constructed before 2005 had more asthma (as 
compared to buildings constructed after 2005) (Wang et al., 2019b). 
Moreover, one study from Sweden found that adults living in newer 
buildings (constructed 1961–1975) had higher prevalence of day time 
breathlessness (as compared to buildings constructed before 1960) 
(Wang et al., 2014a). 
Living in newer buildings (constructed 1986–2001) was related to 
onset of rhinitis symptoms. This is in agreement with one previous study 
from Sweden, reporting that living in buildings constructed 1976–1985 
was associated with more rhinitis among adults in Sweden (as compared 
to buildings constructed before 1960) (Wang et al., 2014a). 
The reason for different associations between building age and upper 
and lower airway symptoms is not clear. Newer buildings can have more 
chemical emissions while older buildings can have more dirt containing 
bioaerosols. One study from Europe found that dampness and mould 
were more common in older buildings (Norback et al., 2017). Moreover, 
two recent studies, from China and Malaysia respectively, investigated 
microbiome richness in buildings and reported that increased building 
age was associated with richer bacteria/fungi composition variation in 
the buildings (Fu et al., 2020a, 2020b). In our study, we adjusted for 
visible dampness and mould in the analyses, but hidden dampness or 
mould can exist in older buildings. Moreover, older buildings could have 
more allergen contamination as compared to newer buildings, and dust 
and dirt can contain microbial compounds. One study from Germany 
found that concentrations of house dust mite allergens and cat allergen 
in dust were higher in older buildings (Fahlbusch et al., 1999). Never-
theless, new buildings can have higher chemical emissions. One study 
from Hong Kong, China found that newly built apartments had higher 
indoor formaldehyde concentrations (Guo et al., 2009). Formaldehyde is 
a water soluble compound mainly affecting the upper airways. Another 
study from Hong Kong concluded that building materials were the major 
source of indoor VOCs (Guo, 2011). One Korean study concluded that 
wood panels/vinyl floor coverings and paints were the main sources of 
indoor VOCs in newly built apartments (Shin and Jo, 2012). Our results 
imply that building age can be an indicator of certain indoor pollutants. 
More specific studies on building factors are needed to identify potential 
indoor hazards related to building age. It can be interesting to study 
change of microbial organisms in relation to building age in future 
studies, since indoor microbiome can influence asthma and rhinitis. 
4.7. Strengths and limitations 
There are several strengths in our study. Firstly, it is the first pro-
spective study from Northern Europe investigating building character-
istics other than dampness and mould in relation to onset and remission 
of adult respiratory symptoms, asthma and rhinitis. Secondly, the 
number of participants was large, giving high statistical power. Data on 
respiratory health associations for dampness in the home have been 
previously published from the study (Wang et al., 2019a). Dampness and 
mould is the most well documented home environment risk factor. Two 
reviews concluded that dampness and mould can increase risk of prev-
alent rhinitis and development of asthma (Quansah et al., 2012; Jaak-
kola et al., 2013). We have adjusted for dampness and mould in the 
models when studying health associations for other home environment 
factors. 
There are some limitations. Our study included only questionnaire 
data, no objective exposure measurements were made. Moreover, we 
had no information on other indoor renovation activities than painting. 
Another limitation is related to symptom reporting. Respiratory symp-
toms were reported for the past 12 months at baseline and at follow up 
(with no information about respiratory symptoms several years before 
the follow up survey), which may not reflect the real onset during the 
study period. Moreover, we did not ask about pet keeping or family 
history of allergies or respiratory diseases, which could be potential 
confounders. 
5. Conclusions 
This prospective study found that smoking can be a risk factor for 
adult onset of respiratory symptoms and rhinitis symptoms. Starting 
smoking can increase onset of respiratory symptoms and quitting 
smoking can decrease the risk. ETS exposure can be a risk factor for 
onset of respiratory symptoms. Chemical emissions from wood or floor 
paints can increase onset and decrease remission of respiratory symp-
toms. However, indoor painting can increase remission of allergic 
rhinitis. Living in older buildings can increase adult onset of nocturnal 
cough and asthma. Living in newer buildings can increase onset of 
nocturnal breathlessness and allergic rhinitis. Our study indicates that 
smoking, especially smoking inside homes, should be avoided. 
Furthermore, health effects of building age and indoor painting needs to 
be investigated in more detailed studies. 
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